WDAY News Alert Workday Inc (WDAY) 83.36 12/06/2014 23:07:24

New Post Public Reply Private Reply Replies (0) Message Board

Dec 7, 2014 at 12:07 AM

Workday Inc (WDAY) 83.36 $WDAY

InsiderInsights.com Daily Round Up 12/4/14: GPRO, XOMA, PSEC, KMT
InsiderInsights - at Seeking Alpha - Fri Dec 05, 5:22PM CST

GPRO: 72.18 (+0.20), CLR: 38.23 (-0.63), PATK: 43.54 (-0.39), JONE: 10.36 (+0.31), RL: 183.30 (+0.14), PRSS: 2.09 (-0.03), KMT: 35.90 (-0.06), TSRA: 34.86 (-0.06), WDAY: 83.36 (+1.07), DYN: 30.43 (-0.44), WRLD: 78.10 (+2.44), OC: 36.15 (-0.32), DATA: 81.79 (+0.74), SFXE: 4.41 (+0.10), PSEC: 8.89 (unch), REPH: 2.84 (+0.14), XOMA: 4.66 (+0.20)

SAP Completes Concur Buyout; Here's What's Next
Joe Panettieri - at Seeking Alpha - Fri Dec 05, 4:44PM CST

SAP: 69.75 (+0.58), IBM: 163.27 (-0.78), WDAY: 83.36 (+1.07), ORCL: 41.93 (+0.04), CRM: 58.85 (-0.10)

Insider Trading Alert - NDAQ, WDAY And NNBR Traded By Insiders
at The Street - Fri Dec 05, 12:45PM CST
Stocks with insider trader activity include NDAQ, WDAY and NNBR
WDAY: 83.36 (+1.07), NNBR: 20.62 (+0.67), NDAQ: 45.68 (-0.26)

The 2014 Class Of SaaS IPOs
Tomasz Tunguz - at Seeking Alpha - Fri Dec 05, 1:05AM CST
2014 has been a great year for SaaS companies. By my count, 9 of them will have gone public. Meanwhile, SaaS companies in both the public and private markets continue to fetch premium valuations. To illustrate the rapid appreciation in the value of...
VEEV: 30.97 (-0.55), NEWR: (), HDP: (), FIVN: 4.48 (unch), WDAY: 83.36 (+1.07), MOBL: 9.35 (+0.27), ZEN: 23.89 (+0.15), DATA: 81.79 (+0.74), HUBS: 33.31 (+0.52)

5 Things Workday Inc. Management Wants You to Know
Keith Noonan, The Motley Fool - Motley Fool - Thu Dec 04, 9:00AM CST
Workday announced its third-quarter earnings recently, delivering results that were better than analyst expectations. Estimates called for $205 million in revenue, with the actual sales coming in at $215.1 million,putting revenues for the quarter...
SAP: 69.75 (+0.58), WDAY: 83.36 (+1.07), UL: 42.42 (+0.31), ORCL: 41.93 (+0.04)

Critical Alerts For Micron, FutureFuel, First Solar, Workday and Cheniere Energy Released By InvestorsObserver
PR Newswire - Thu Dec 04, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for MU, FF, FSLR, WDAY and LNG.
MU: 36.49 (+0.42), FSLR: 46.91 (+0.19), WDAY: 83.36 (+1.07), LNG: 70.76 (+0.57), FF: 12.14 (+0.33)

Workday: The Risks And Opportunities
Stock Dmitry - at Seeking Alpha - Tue Dec 02, 7:30AM CST

WDAY: 83.36 (+1.07)

Insider Selling And No Path To Profitability Should Weigh On Zendesk
Amit Ghate - at Seeking Alpha - Tue Dec 02, 5:15AM CST

NOW: 62.63 (+0.13), WDAY: 83.36 (+1.07), ZEN: 23.89 (+0.15)

Tesla, 4 Other Stocks Break This Key Resistance Level
at Investor's Business Daily - Mon Dec 01, 3:33PM CST
Leading stocks often find support at the 50-day moving average -- or discover that mutual funds won't support them. But investors should also pay attention to the 200-day moving average, a longer-term line that can be a last-ditch support level. Here...
AMZN: 312.63 (-4.30), TSLA: 223.71 (-4.57), YY: 67.13 (+0.80), WDAY: 83.36 (+1.07), TRLA: 51.17 (+1.71), BABA: 107.90 (-1.27), Z: 118.73 (+3.57)

Workday - Modest Correction As Investors Fear Growth Slowdown Over Conservativeness
The Value Investor - at Seeking Alpha - Mon Dec 01, 1:41AM CST

WDAY: 83.36 (+1.07)

Why Oracle Should Buy Workday
Brian Nichols - at Seeking Alpha - Fri Nov 28, 8:47AM CST

WDAY: 83.36 (+1.07), ORCL: 41.93 (+0.04)

Deere and Seadrill are big market movers
AP - Wed Nov 26, 3:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:
CPRT: 37.76 (+0.56), BLOX: 18.24 (+0.32), BECN: 28.00 (+0.87), SDRL: 12.32 (-0.01), CUB: 54.94 (+0.04), ANFI: 12.67 (-0.55), HAIN: 115.33 (+1.26), DSW: 34.65 (-0.15), CBRL: 131.73 (+2.95), PLL: 98.41 (-0.02), WDAY: 83.36 (+1.07), DE: 89.73 (+0.16), CTRP: 44.91 (-2.28), TASR: 24.82 (+0.67), CASY: 82.63 (+0.13)

3 Reasons Workday Inc.'s Stock Could Fall
Keith Noonan, The Motley Fool - Motley Fool - Wed Nov 26, 10:13AM CST
Workday 's share price has seen significant volatility over the last year, but the stock has risen roughly 17% over the period. Prior to the announcement of the company's third-quarter report earlier this week, the past month saw shares climb...
SAP: 69.75 (+0.58), WDAY: 83.36 (+1.07), ORCL: 41.93 (+0.04)

NYSE stocks posting largest percentage decreases
AP - Tue Nov 25, 5:58PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:
KOG: 6.56 (-0.39), CBI: 45.92 (-0.15), CRR: 37.47 (+0.60), CLV: 7.54 (-0.01), NKA: 4.23 (-0.31), NS: 54.68 (-1.30), WTI: 6.49 (-0.02), CLF: 7.97 (-0.06), HRL: 52.77 (+0.27), TDW: 31.15 (-1.71), ANFI: 12.67 (-0.55), GDP: 3.71 (-0.20), TCK: 14.57 (-0.15), WDAY: 83.36 (+1.07), CRK: 6.68 (-0.15)

Workday -6.1%; Street debates guidance, deferred revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 1:51PM CST

WDAY: 83.36 (+1.07)

Stocks Mixed Near Midday; Palo Alto Surges On Earnings
at Investor's Business Daily - Tue Nov 25, 10:58AM CST
Stocks were narrowly mixed near Tuesday's halftime after a morning rally brought on by mostly better-than-expected economic data lost steam. The S&P 500 was off by 0.1% and the Dow Jones industrial average was fractionally lower. Meanwhile, the...
NFLX: 350.92 (+0.32), VDSI: 29.15 (+0.14), WDAY: 83.36 (+1.07), PANW: 118.88 (+0.59)

Workday Takes Investor Heat For Light Outlook
at Investor's Business Daily - Tue Nov 25, 10:41AM CST
Workday (WDAY) may be a victim of its own conservatism. Shares of the enterprise software company fell more than 5% in morning trading in the stock market today, one day after the company reported a revenue forecast for the current period that was...
SAP: 69.75 (+0.58), IBM: 163.27 (-0.78), WDAY: 83.36 (+1.07), ORCL: 41.93 (+0.04)

Workday (WDAY) Earnings Report: Q3 2015 Conference Call Transcript
at The Street - Tue Nov 25, 10:20AM CST
The following Workday (WDAY) conference call took place on November 24, 2014, 05:00 PM ET. This is a transcript of that earnings call:
WDAY: 83.36 (+1.07)

Stocks Turn Lower After Consumer Confidence Declines Unexpectedly
at The Street - Tue Nov 25, 10:17AM CST
U.S. stocks slip from session highs on Tuesday, even after third-quarter GDP posts a surprise jump to 3.9% from an initial reading of 3.5%.
DSW: 34.65 (-0.15), SAN: 8.99 (+0.11), WDAY: 83.36 (+1.07), CPB: 43.65 (unch), TIF: 107.46 (+0.13), HRL: 52.77 (+0.27), AAPL: 115.00 (-0.49)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...